CEO, Stephen Van Deventer, Discusses Recent Developments with Proactive Investor's, Steve Darling.
September 24, 2018
PreveCeutical Medical Inc. (CSE:PREV) CEO and President, Stephen Van Deventer, joined Steve Darling in the Vancouver studio of Proactive Investors to talk about the company’s recent developments. With all of the exciting advances that Preveceutical's curriculum has to offer, paving the path towards health conscious consumers has been an exciting process. Please see the attached link below to view the interview.
On Behalf of the Board,
Stephen Van Deventer Chairman & CEO PreveCeutical Medical Inc.
For further information, please send an email to:info@preveceutical.com